[Ip-health] Fwd: Cites to a German compulsory license, in a 2002 US patent application

Jamie Love james.love at keionline.org
Mon Mar 3 07:38:46 PST 2014


I just ran across these references to a German compulsory licensing case,
in this 2002 US Patent, No 6,458,527:


United States Patent US 6,458,527 B1
Oct. 1, 2002
HIV IMMUNOASSAYS USING GAG POLYPEPTIDES

Assignee: Chiron Corporation,

Other Publications

Translation of Action for Grant of Compulsory License to EP 0 181 150, Jul.
3, 2000.

Interlocutory Decision in Opposition Proceedings 85 307 860.8, Mar. 10,
1998 (English translation, Exhibit K2 filed in compulsory license action
[D3]).

Interlocutory Decision in Opposition Proceedings 85 307 860.8, Mar. 10,
1998 (original German, Exhibit K2a filed in compulsory license action
[D3]).

Documents submitted to EPO by Chiron for maintaining EP 0 181 150 (Exhibit
K3 filed in compulsory license action [D3]), 1997.

Minutes of Oral Proceedings in T351/98--334, Nov. 2, 3, and 4, 1999 (Exhibit
K4 filed in compulsory license action [930

Main Request and four auxiliary requests (Exhibit K5 filed in compulsory
license action [D3]), Jan. 1999.

Copy from Rompp's Lexikon der Chemie, 10th ed., Stut tgart/New York, 1999
(Exhibit K6 filed in compulsory license action [D3]).

Copy from Rompp's Lexikon der Biotechnologie und Gen technik, 2d ed.,
Stuttgart/NewYork, 1999 (Exhibit K7) filed in compulsory license action
[D3]).

Product description of Amplicor HIV--1 MonitorTM Test, Version 1.5, Nov.
1998 (Exhibit K8 filed in compulsory license action [D3]).

Product description of COBAS HIV--1 MonitorTM Test, version 1.5, May 1999
(Exhibit K9 filed in compulsory license action [D3]).

Product description of Amplicor(R) HIV--1 Test, Aug. 1998 (Exhibit K10 filed
in compulsory license action [D3]).

Expert opinion by Prof. Dr. med LutZ Giirtler (Exhibit K11 filed in
compulsory license action [D3]) Jun. 2000.

Erice et al., Performance Characteristics of the bDNA 3.0 Assay for
Quantitation of HIV--1 RNA in Plasma, Poster

Session (Exhibit K12 filed in compulsory license action [D3]), 2000.

Roland et al., Pitfalls of HIV RNA testing in the San Francisco
Post--Exposure Prevention Project, presented at the 6th Conference on
retroviruses and Opportunistic Infec tions (Chicago, Feb., 1999) (Exhibit
K13 filed in compul sory license action [D3]).

PereZ et al., Evaluation of the NeW Quantiplex 3.0 HIV bDNAAsay (Q3):
Acomparison With Quantiplex 2.0 (Q2), presented at the 6th Conference on
retroviruses and Oppor tunistic Infections (Chicago, Feb., 1999) (Exhibit
K14 filed in compulsory license action [D3]).

Decision of the 4th Division for Civil Matters of the Regional Court
Diisseldorf pronounced May 18, 2000 (original German, Exhibit K15 filed in
compulsory license action [D3]).

Decision of the 4"1 Division for Civil Matters of the Regional Court
Diisseldorf pronounced May 18, 2000 (English translation of Exhibit K15
filed in compulsory license action [D3]).

Letter to William Green, Chiron Corporation, dated Jun. 2, 1999 (Exhibit
K16 filed in compulsory license action [D3]).

Letter to William Green, Chiron Corporation, dated May 19, 2000 (Exhibit
K17 filed in compulsory license action [D3]).

HIV/AIDS/STI Surveillance, WWW.Who.int/health.topics/ hiv.htm, Exhibit K18
filed in compulsory license action [D3]), 2000.

Allgemeines Zu den epidemiologischen Seiten iiber HIV/ AIDS, Robert
Koch--Institut, 1999 (Exhibit K19 filed in compulsory license action [D3]).

Remarks as prepared for delivery by Vice President Al Gore, United Nations
Security Council Opening Session, Jan. 10, 2000 (Exhibit K20 filed in
compulsory license action [D3]).

Statement by Dr. Andreas Plettenberg, HAART 1998-- Moglichkeiten und
GrenZen, 1998 (Exhibit K21 filed in compulsory license action [D3]).

Declaration by Prof. Dr. med. Noll (Exhibit K22 filed in compulsory license
action [D3]), Jun. 2000.

Declaration of Prof. Dr. Peterson (Exhibit K23 filed in compulsory license
action [D3]), May 2000.

Declaration by the joint practice of Dr. med. Knechten, Dr. med HabetZ
dated Jun. 5, 2000 (Exhibit K24 filed in compulsory license action




-- 
James Love.  Knowledge Ecology International
http://www.keionline.org, KEI DC tel: +1.202.332.2670, US Mobile:
+1.202.361.3040, Geneva Mobile: +41.76.413.6584,   twitter.com/jamie_love



More information about the Ip-health mailing list